ABSTRACT T-cells comprise many subtypes of specified lymphocytes, and their
differentiation and function take place in different tissues. This cellular diversity is also …

Malignancies of thymus-derived (T) lymphocytes can be divided into two major groups:
diseases of T cells expressing immature T cell markers (T-ALL, T cell lymphoblastic …

T‐cell lymphoproliferative disorders, a group of neoplastic disease that result from the clonal
proliferation of mature post‐thymic T‐lymphocytes, are classified on the basis of their clinical …

T-cell and NK-cell lymphomas are uncommon lymphomas with an aggressive clinical
course. The causes and precise cellular origins of most T-cell lymphomas are still not well …

Untreated T cell malignancies (82) and T leukaemic cell lines (13) have been analysed by
fluorescence microscopy and flow cytometry (FACS) using a series of monoclonal …

The distribution of the conventional lymphoid cell markers on T lymphocytes and the
principal panels of monoclonal antibodies used to recognize distinctive T-lymphocyte …

T-cell malignancies represent a broad, highly heterogeneous grouping of clinicobiological
entities, some of which are defined by exclusion. Although T-cell acute lymphoblastic …

Twenty-three T-cell neoplasms were investigated for their reactivity with the OKT monoclonal
antibodies and expression of certain cytochemical markers. Fourteen neoplasms with …

The development of T cells from stem (progenitor) cells to effector cells results from a two-
wave process of proliferation and differentiation. The cells of the first differentiation wave are …

Accumulating experimental and clinical evidence has been obtained over recent years in
support of the notion that the immune system has the potential to cure cancer. The most …